DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 206531
The generic ingredient in FAMOTIDINE is calcium carbonate; famotidine; magnesium hydroxide. There are two hundred and seventy-five drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the calcium carbonate; famotidine; magnesium hydroxide profile page.
Summary for 206531
Tradename: | FAMOTIDINE |
Applicant: | Aurobindo Pharma Ltd |
Ingredient: | famotidine |
Patents: | 0 |
Therapeutic Class: | Gastrointestinal Agents |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 206531
Suppliers and Packaging for NDA: 206531
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
FAMOTIDINE | famotidine | TABLET;ORAL | 206531 | ANDA | Wal-Mart Stores, Inc. | 49035-505 | N | 49035-505-35 |
FAMOTIDINE | famotidine | TABLET;ORAL | 206531 | ANDA | Magno-Humphries, Inc. | 54257-180 | N | 54257-180-07 |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Apr 26, 2016 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
Approval Date: | Apr 26, 2016 | TE: | RLD: | No |
Complete Access Available with Subscription